Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer.
Nature. 2023 Nov;623(7986):415-422. doi: 10.1038/s41586-023-06685-2. Epub 2023 Nov 1.
Nature. 2023.
PMID: 37914939
Free article.
The dark side of immunotherapy: pancreatic cancer.
Mucciolo G, Roux C, Scagliotti A, Brugiapaglia S, Novelli F, Cappello P.
Mucciolo G, et al. Among authors: brugiapaglia s.
Cancer Drug Resist. 2020 May 11;3(3):491-520. doi: 10.20517/cdr.2020.13. eCollection 2020.
Cancer Drug Resist. 2020.
PMID: 35582441
Free PMC article.
Review.
Item in Clipboard
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer.
Curcio C, Brugiapaglia S, Bulfamante S, Follia L, Cappello P, Novelli F.
Curcio C, et al. Among authors: brugiapaglia s.
Molecules. 2021 Mar 15;26(6):1642. doi: 10.3390/molecules26061642.
Molecules. 2021.
PMID: 33804240
Free PMC article.
Review.
Item in Clipboard
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Curcio C, Rosso T, Brugiapaglia S, Guadagnin G, Giordano D, Castellino B, Satolli MA, Spadi R, Campra D, Moro F, Papotti MG, Bertero L, Cassoni P, De Angelis C, Langella S, Ferrero A, Armentano S, Bellotti G, Fenocchio E, Nuzzo A, Ciccone G, Novelli F.
Curcio C, et al. Among authors: brugiapaglia s.
Clin Exp Med. 2023 Dec;23(8):5089-5100. doi: 10.1007/s10238-023-01236-5. Epub 2023 Nov 1.
Clin Exp Med. 2023.
PMID: 37910256
Free PMC article.
Item in Clipboard
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
Farias TDJ, Brugiapaglia S, Croci S, Magistroni P, Curcio C, Zguro K, Fallerini C, Fava F, Pettini F, Kichula KM, Pollock NR, Font-Porterias N, Palmer WH, Marin WM, Baldassarri M, Bruttini M, Hollenbach JA, Hendricks AE, Meloni I, Novelli F; GEN-COVID Multicenter Study Group; Renieri A, Furini S, Norman PJ, Amoroso A.
Farias TDJ, et al. Among authors: brugiapaglia s.
HLA. 2024 Jan;103(1):e15251. doi: 10.1111/tan.15251. Epub 2023 Oct 18.
HLA. 2024.
PMID: 37850268
Free article.
Item in Clipboard
Cite
Cite